| Targeting macrophage dysregulation for viral infections: Novel targets for immunomodulators MD Reece, RR Taylor, C Song, C Gavegnano Frontiers in Immunology 12, 768695, 2021 | 11 | 2021 |
| Repurposing BCL-2 and Jak 1/2 inhibitors: Cure and treatment of HIV-1 and other viral infections MD Reece, C Song, SC Hancock, S Pereira Ribeiro, DA Kulpa, ... Frontiers in Immunology 13, 1033672, 2022 | 5 | 2022 |
| A rationale and approach to the development of specific treatments for HIV associated neurocognitive impairment A Scanlan, Z Zhang, R Koneru, M Reece, C Gavegnano, AM Anderson, ... Microorganisms 10 (11), 2244, 2022 | 3 | 2022 |
| The identification of intact HIV proviral DNA from human cerebrospinal fluid Z Zhang, MD Reece, S Roa, W Tyor, DR Franklin, SL Letendre, ... Neurotherapeutics, e00373, 2024 | | 2024 |
| Honokiol hexafluoro confers reversal of neuropathological markers of HIV infection in a murine SCID model Z Zhang, A Scanlan, R Koneru, CR Morrell, MD Reece, E Edwards, S Roa, ... Neurotherapeutics, e00329, 2024 | | 2024 |
| Ex Vivo Differentiation of Resting CD4+ T Lymphocytes Enhances Detection of Replication Competent HIV-1 in Viral Outgrowth Assays ER Wonderlich, MD Reece, DA Kulpa HIV Reservoirs: Methods and Protocols, 315-331, 2022 | | 2022 |
Christina GavegnanoAssistant Professor of Pathology, Pharmacology and Chemical Biology, Emory University,Verified email at emory.edu
